As HSP60 possesses an emerging role in modulating inflammatory conditions, whether its folding activity is implicated in mt-dsRNA restriction in the context of NAFLD remains unanswered. Here, HSPD1 is linked to metabolic dysfunction-associated steatotic liver disease.